The Sileach process isn't that far along yet to be used in a trade-off study for comparison of operating costs and such. Would Sileach fare any better? It's not possible to know at this stage. All we can safely say for now, with factual evidence, is, the EMH trade-off study has concluded that it's far more viable on multiple price and risk levels to use a roasting process rather than L-max.
That's a serious cause for concern for Lepidico at this stage as i assume their entire revenue model is leveraged off L-max licensing and royalties.
Whether EMH have got it right or wrong, only time will tell..
The Sileach process isn't that far along yet to be used in a...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $24.85M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $31.50K | 1.520M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 6773810 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 453534 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| LIT (ASX) Chart |